Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysone

NCT04827537 is registered in ClinicalTrials.gov with Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan as lead sponsor.

NCT NCT04827537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04827537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysone
Lead sponsor
Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
January 1, 2021
Completion date
December 31, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

giardia lamblia infection